[go: up one dir, main page]

WO2019004968A3 - Utilisation d'une formulation végétale contenant de l'huile de pépins de grenade comme agent renforçant le système immunitaire du fait de sa fonction antioxydante - Google Patents

Utilisation d'une formulation végétale contenant de l'huile de pépins de grenade comme agent renforçant le système immunitaire du fait de sa fonction antioxydante Download PDF

Info

Publication number
WO2019004968A3
WO2019004968A3 PCT/TR2018/050157 TR2018050157W WO2019004968A3 WO 2019004968 A3 WO2019004968 A3 WO 2019004968A3 TR 2018050157 W TR2018050157 W TR 2018050157W WO 2019004968 A3 WO2019004968 A3 WO 2019004968A3
Authority
WO
WIPO (PCT)
Prior art keywords
seed oil
vegetal
pomegranate seed
immune system
antioxidant function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2018/050157
Other languages
English (en)
Other versions
WO2019004968A9 (fr
WO2019004968A2 (fr
Inventor
Mevlüt Büyükhelvacigi̇l
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS
Original Assignee
Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS filed Critical Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS
Publication of WO2019004968A2 publication Critical patent/WO2019004968A2/fr
Publication of WO2019004968A3 publication Critical patent/WO2019004968A3/fr
Publication of WO2019004968A9 publication Critical patent/WO2019004968A9/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne l'utilisation d'une formulation végétale dans l'industrie pharmaceutique préparée sous forme de capsules par recours à de l'huile de pépins de grenade riche en acides gras essentiels, tels que l'acide punicique (oméga 5) comme agent renforçant le système immunitaire du fait de la fonction antioxydante de la formulation dans la protection de la santé, comprenant de l'huile de pépins de grenade, du dl-a-tocophérol, l'acétate de dl-a-tocophéryle, de la glycérine, de l'eau purifiée et de la gélatine qui procure l'intégrité du contenu et la formation en capsules.
PCT/TR2018/050157 2017-04-19 2018-04-10 Utilisation d'une formulation végétale contenant de l'huile de pépins de grenade comme agent renforçant le système immunitaire du fait de sa fonction antioxydante Ceased WO2019004968A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2017/05828 2017-04-19
TR2017/05828A TR201705828A2 (tr) 2017-04-19 2017-04-19 Nar tohumu yaği i̇çeren bi̇r bi̇tki̇sel formülasyonun anti̇oksi̇dan özelli̇ği̇nden dolayi bağişiklik si̇stemi̇ni̇ güçlendi̇ri̇ci̇ olarak kullanimi

Publications (3)

Publication Number Publication Date
WO2019004968A2 WO2019004968A2 (fr) 2019-01-03
WO2019004968A3 true WO2019004968A3 (fr) 2019-02-14
WO2019004968A9 WO2019004968A9 (fr) 2019-04-11

Family

ID=64743059

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2018/050157 Ceased WO2019004968A2 (fr) 2017-04-19 2018-04-10 Utilisation d'une formulation végétale contenant de l'huile de pépins de grenade comme agent renforçant le système immunitaire du fait de sa fonction antioxydante

Country Status (2)

Country Link
TR (1) TR201705828A2 (fr)
WO (1) WO2019004968A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1011021B (el) * 2024-01-17 2025-09-01 Στεφανος Θεοδωρου Κασσιδης Μεθοδος παραγωγης ελαιου απο σπορους ροδιου

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189283A (zh) * 2014-09-04 2014-12-10 上海浦东高星生物技术研究所 石榴籽油滴丸
CN105963350A (zh) * 2016-03-16 2016-09-28 安徽珠峰生物科技有限公司 一种天然维生素e软胶囊

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189283A (zh) * 2014-09-04 2014-12-10 上海浦东高星生物技术研究所 石榴籽油滴丸
CN105963350A (zh) * 2016-03-16 2016-09-28 安徽珠峰生物科技有限公司 一种天然维生素e软胶囊

Also Published As

Publication number Publication date
WO2019004968A9 (fr) 2019-04-11
TR201705828A2 (tr) 2017-07-21
WO2019004968A2 (fr) 2019-01-03

Similar Documents

Publication Publication Date Title
PH12020550341A1 (en) Niraparib formulations
BR112012026758A2 (pt) cápsula, método para produzir cápsulas com uma estrutura de núcleo/envoltório, usos de cápsulas com uma estrutura de núcleo/envoltório, e de preparações pulverulentas ou líquidas, e, composição farmacêutica, de cosméticos, preparação de proteção de cultura, alimentação de animal, suplemento alimetar ou nutricional
BR112012026596A2 (pt) método para preparar composições farmacêuticas pretendidas para administração oral compreendendo um ou mais ingredientes ativos e as composições que compreendem as mesmas
EP4445959A3 (fr) Formulations pharmaceutiques de statines et d'acides gras oméga-3 pour encapsulation
RU2014119376A (ru) Система нового покрытия
US8518438B2 (en) Highly concentrated liquid acetaminophen solutions
WO2019023039A3 (fr) Compositions pour améliorer la biodisponibilité de produits pharmaceutiques, de compléments et de substances ingérées
PH12017500269B1 (en) Composite formulation for oral administration comprising omega-3 fatty acid esters and statins
TR201821157T4 (tr) İbandroni̇k asi̇t veya bunun farmasöti̇k olarak kabul edi̇lebi̇li̇r bi̇r tuzu ve d vi̇tami̇ni̇ i̇çeren oral uygulamaya yöneli̇k kati bi̇leşi̇m.
NO20084478L (no) Konjugerte lipidderivater
CA3025425C (fr) Comprimes a teneur elevee en ingredient actif de sels d'acides amines d'acides gras omega-3
WO2019004968A3 (fr) Utilisation d'une formulation végétale contenant de l'huile de pépins de grenade comme agent renforçant le système immunitaire du fait de sa fonction antioxydante
PE20220942A1 (es) COMPOSICION DE UN INHIBIDOR DE PI4KIIIalfa DE MOLECULA PEQUENA, METODO DE PREPARACION Y APLICACION DEL MISMO
HRP20171485T1 (hr) Farmaceutski pripravci koji sadrže alisporivir
ATE452120T1 (de) Fettsäure-benzenediol-derivate sowie herstellungs-und verwendungsverfahren dafür
MX387178B (es) Preparaciones de vitaminas que contienen galato de propilo.
WO2019004969A3 (fr) Utilisation d'une formulation végétale contenant de l'huile de graines de grenade comme agent auxiliaire dans la réduction de lipides sanguins dits « triglycérides »
RU2016112012A (ru) Смазывающая композиция для рта
UA117416C2 (uk) Лікарський засіб у формі сиропу для орального застосування широкого спектра дії
HK1221598A2 (zh) 口服药物组合物以及治疗或预防疾病的方法
EA201692398A1 (ru) Гомогенная композиция для перорального введения, содержащая омега-3 полиненасыщенные жирные кислоты и ресвератрол
JP2017019750A (ja) 経口組成物
WO2017160694A3 (fr) Compositions destinées à fournir de la vitamine d à la peau
AR097148A1 (es) Composición alimenticia para rumiantes y método para prepararla
WO2018222167A3 (fr) Utilisation d'une préparation à base de plantes contenant de l'huile de lin dans le traitement de maladies du système cardiovasculaire

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18823680

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18823680

Country of ref document: EP

Kind code of ref document: A2